4DMedical Limited (ASX:4DX)
Australia · Delayed Price · Currency is AUD 3.730
+0.040 (1.08%)
Feb 26, 2026, 2:19 PM AEST
4DMedical Market Cap
4DMedical has a market cap or net worth of 2.11 billion as of February 25, 2026. Its market cap has increased by 929.96% in one year.
Market Cap
2.11B
Enterprise Value
2.11B
Revenue
5.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.73
Market Cap Chart
Since August 7, 2020, 4DMedical's market cap has increased from 420.97M to 2.11B, an increase of 401.55%. That is a compound annual growth rate of 33.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 2.11B | 0.66% |
| Dec 31, 2025 | 2.10B | 961.67% |
| Dec 31, 2024 | 197.57M | -29.31% |
| Dec 29, 2023 | 279.48M | 125.82% |
| Dec 30, 2022 | 123.76M | -68.87% |
| Dec 31, 2021 | 397.56M | -38.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 7, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cochlear | 12.88B |
| Anteris Technologies Global | 836.20M |
| PolyNovo | 649.39M |
| Aroa Biosurgery | 226.29M |
| Lumos Diagnostics Holdings | 206.24M |
| EMVision Medical Devices | 163.57M |
| SomnoMed | 144.17M |
| Cleo Diagnostics | 82.12M |